Back
Beam Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
BEAM
Beam Therapeutics
Last Price:
$20.60
Seasonality Move:
-11.63%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and BEAM is experiencing slight selling pressure.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.62 | Sell |
20-day SMA: | 18.72 | Buy |
50-day SMA: | 17.87 | Buy |
200-day SMA: | 22.88 | Sell |
8-day EMA: | 20.22 | Sell |
20-day EMA: | 19.28 | Buy |
50-day EMA: | 18.79 | Buy |
200-day EMA: | 21.93 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.88 | Buy |
Relative Strength Index (14 RSI): | 56.66 | Buy |
Chaikin Money Flow: | -82212 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.68 - 20.24) | Buy |
Bollinger Bands (100): | (15.8 - 24.14) | Buy |
Beam Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 20.07 while BEAM 8-day simple moving average is 20.62, which is a Sell signal.
-
The stock price of BEAM is 20.07 while Beam Therapeutics 20-day SMA is 18.72, which makes it a Buy.
-
Beam Therapeutics 50-day simple moving average is 17.87 while BEAM share price is 20.07, making it a Buy technically.
-
BEAM stock price is 20.07 and Beam Therapeutics 200-day simple moving average is 22.88, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
37
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a SellThe current Beam Therapeutics [BEAM] share price is $20.07. The Score for BEAM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2B
Price in USD:
20.07
Share Volume:
2.1M
Beam Therapeutics 52-Week Range
52-Week High:
35.25
52-Week Low:
13.53
Sell
37
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?The Beam Therapeutics stock price is 20.07 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 20.07 while BEAM 8-day exponential moving average is 20.22, which is a Sell signal.
-
The stock price of BEAM is 20.07 while Beam Therapeutics 20-day EMA is 19.28, which makes it a Buy.
-
Beam Therapeutics 50-day exponential moving average is 18.79 while BEAM share price is 20.07, making it a Buy technically.
-
BEAM stock price is 20.07 and Beam Therapeutics 200-day simple moving average is 21.93, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.02 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is 0.88, suggesting Beam Therapeutics is a Buy
-
Beam Therapeutics Relative Strength Index (RSI) is 56.66, which suggest Beam Therapeutics is overbought
-
The Bollinger Bands (25) for Beam Therapeutics is (16.68 - 20.24), which suggest Beam Therapeutics is a Buy
-
The Bollinger Bands (100) for Beam Therapeutics is (15.8 - 24.14), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.